{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:36:22Z","timestamp":1789590982184,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.socscimed.2006.08.023","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T12:04:53Z","timestamp":1159877093000},"page":"174-185","source":"Crossref","is-referenced-by-count":15,"title":["Variant Creutzfeldt\u2013Jakob disease and the Canadian blood system after the tainted blood tragedy"],"prefix":"10.1016","volume":"64","author":[{"given":"Kumanan","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Laupacis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.socscimed.2006.08.023_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198104233041701","article-title":"Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The transfusion-transmitted viruses study","volume":"304","author":"Aach","year":"1981","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.socscimed.2006.08.023_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.246.6.630","article-title":"Donor transaminase and recipient hepatitis. Impact on blood transfusion services","volume":"246","author":"Alter","year":"1981","journal-title":"Journal of The American Medical Association"},{"key":"10.1016\/j.socscimed.2006.08.023_bib3","series-title":"Policy alternatives in transfusion medicine","article-title":"Making decisions to improve transfusion safety","author":"AuBuchon","year":"2001"},{"key":"10.1016\/j.socscimed.2006.08.023_bib4","series-title":"Creutzfeldt\u2013Jakob disease, blood and blood products: A bioethics framework","year":"1998"},{"key":"10.1016\/j.socscimed.2006.08.023_bib5","unstructured":"Bayer, R., & Feldman, E.A. (1999). Understanding the blood feuds. In F. E. A., B. R. (Eds.), Blood feuds. Aids, blood, and the politics of medical disaster. Oxford: Oxford University Press."},{"issue":"8941","key":"10.1016\/j.socscimed.2006.08.023_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0140-6736(95)91153-7","article-title":"Post-transfusion hepatitis: Impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group","volume":"345","author":"Blajchman","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.socscimed.2006.08.023_bib7","series-title":"Performance review of Canadian blood services","article-title":"CBS response and action plan\u2014summary","year":"2003"},{"key":"10.1016\/j.socscimed.2006.08.023_bib8","series-title":"Rising to the challenge. A report to Canadians 2003\/4","article-title":"Safety of products","year":"2004"},{"key":"10.1016\/j.socscimed.2006.08.023_bib9","unstructured":"Canadian Hemophilia Society. (2005). Report card on Canada's blood system 7 years after the Commission of Inquiry on the blood system in Canada. Blood Safety Committee of the Canadian Hemophilia Society."},{"key":"10.1016\/j.socscimed.2006.08.023_bib10","series-title":"New variant Creutzfeldt\u2013Jakob disease and the Canadian blood supply: Scientific basis of risk","author":"Cashman","year":"1999"},{"issue":"3","key":"10.1016\/j.socscimed.2006.08.023_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.pubjof.a038209","article-title":"Deregulating federalism? The politics of mandate reform in the 104th Congress","volume":"25","author":"Conlan","year":"1995","journal-title":"Publius"},{"issue":"3","key":"10.1016\/j.socscimed.2006.08.023_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-3148.2001.00310.x","article-title":"Pathogen inactivation of labile blood products","volume":"11","year":"2001","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1016\/j.socscimed.2006.08.023_bib13","series-title":"Comprehensive risk assessment for vCJD in France and other countries for Canadians and the Canadian blood supply","author":"ElSaadany","year":"2000"},{"key":"10.1016\/j.socscimed.2006.08.023_bib14","series-title":"Minutes. Item 2","year":"1998"},{"key":"10.1016\/j.socscimed.2006.08.023_bib15","unstructured":"FDA. (January 2002). Guidance for industry. In F. a. D. A (Ed.), Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt\u2013Jakob disease (CJD) and variant Creutzfeldt\u2013Jakob disease (vCJD) by blood and blood products. US Department of Health and Human Services, Center for Biologics Evaluation and Research (CBER)."},{"key":"10.1016\/j.socscimed.2006.08.023_bib16","unstructured":"Gilmore, N., & Somerville, M.A. (1999). From trust to tragedy: HIV\/AIDS and the Canadian blood system. In B. R. Feldman, E. A. (Ed.), Blood feuds. Aids, blood and the politics of medical disaster. Oxford: Oxford University Press."},{"issue":"12","key":"10.1016\/j.socscimed.2006.08.023_bib17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1046\/j.1537-2995.2000.40121522.x","article-title":"The case against universal WBC reduction (and for the practice of evidence-based medicine)","volume":"40","author":"Goodnough","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.socscimed.2006.08.023_bib18","series-title":"Policy analysis for the real world","article-title":"Models of policy making","author":"Hogwood","year":"1984"},{"key":"10.1016\/j.socscimed.2006.08.023_bib19","unstructured":"IBM Consulting. (2002). Executive summary. In performance review of Canadian blood services. Final Report."},{"key":"10.1016\/j.socscimed.2006.08.023_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0143814X00007431","article-title":"Evaluating the advocacy coalition framework","volume":"14","author":"Jenkins-Smith","year":"1994","journal-title":"Journal of Public Policy"},{"key":"10.1016\/j.socscimed.2006.08.023_bib21","series-title":"Commission of inquiry on the blood system in Canada. Final Report","article-title":"The Consequences of the Contamination of the blood Supply. Chapter 26","author":"Krever","year":"1997"},{"key":"10.1016\/j.socscimed.2006.08.023_bib22","series-title":"Commission of inquiry on the blood system in Canada. Final Report","article-title":"The blood system for the future. Chapter 40","author":"Krever","year":"1997"},{"key":"10.1016\/j.socscimed.2006.08.023_bib23","series-title":"Commission of inquiry on the blood system in Canada. Final Report","article-title":"Canada's rejection of surrogate testing","author":"Krever","year":"1997"},{"issue":"4","key":"10.1016\/j.socscimed.2006.08.023_bib24","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"146","author":"Laupacis","year":"1992","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.socscimed.2006.08.023_bib25","article-title":"France acts on threat of BSE transmission by blood. The French blood transfusion authorities are banning donors who might have become exposed to BSE in the UK","author":"Lee","year":"2001","journal-title":"The Scientist"},{"issue":"9407","key":"10.1016\/j.socscimed.2006.08.023_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.socscimed.2006.08.023_bib27","first-page":"140","article-title":"Connecting research and policy","author":"Lomas","year":"2000","journal-title":"Canadian Journal of Policy Research"},{"key":"10.1016\/j.socscimed.2006.08.023_bib28","unstructured":"Medicare Payment Advisory Committee. (2001). Blood safety in hospitals and medicare inpatient payment. Report to the Congress."},{"key":"10.1016\/j.socscimed.2006.08.023_bib29","series-title":"Rethinking risk and the precautionary principle","article-title":"Defining the precautionary principle","author":"Morris","year":"2000"},{"issue":"3","key":"10.1016\/j.socscimed.2006.08.023_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1017\/S0008423902778323","article-title":"The politics of naming, blaming and claiming: HIV, Hepatitis C, and the Emergence of Blood Activism in Canada","volume":"35","author":"Orsini","year":"2002","journal-title":"Canadian Journal of Political Science"},{"key":"10.1016\/j.socscimed.2006.08.023_bib31","series-title":"Public policy analysis","author":"Pal","year":"1992"},{"issue":"9433","key":"10.1016\/j.socscimed.2006.08.023_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.socscimed.2006.08.023_bib33","series-title":"The gift of death. Confronting Canada's tainted-blood tragedy","author":"Picard","year":"1998"},{"key":"10.1016\/j.socscimed.2006.08.023_bib34","article-title":"RCMP Lay 32 charges in tainted-blood case","author":"Picard","year":"2002","journal-title":"Globe and Mail"},{"issue":"Suppl. 1","key":"10.1016\/j.socscimed.2006.08.023_bib35","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0264-410X(01)00303-6","article-title":"Lessons learned concerning vaccine safety","volume":"20","author":"Plotkin","year":"2001","journal-title":"Vaccine"},{"issue":"4542","key":"10.1016\/j.socscimed.2006.08.023_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause Scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.socscimed.2006.08.023_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/0164025987008004005","article-title":"Knowledge, policy-oriented learning, and policy change. An advocacy coalition framework","volume":"8","author":"Sabatier","year":"1987","journal-title":"Knowledge: Creation, Diffusion, Utilization"},{"key":"10.1016\/j.socscimed.2006.08.023_bib38","series-title":"Theories of the policy process","article-title":"The need for better theories","author":"Sabatier","year":"1993"},{"key":"10.1016\/j.socscimed.2006.08.023_bib39","series-title":"Policy change and learning. An advocacy coalition approach","article-title":"Policy change over a decade or more","author":"Sabatier","year":"1993"},{"issue":"4799","key":"10.1016\/j.socscimed.2006.08.023_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1126\/science.3563507","article-title":"Perception of risk","volume":"236","author":"Slovic","year":"1987","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.socscimed.2006.08.023_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0033-3549(04)50199-1","article-title":"The precautionary principle and emerging biological risks: Lessons from swine flu and HIV in blood products","volume":"117","author":"Stoto","year":"2002","journal-title":"Public Health Report"},{"issue":"7","key":"10.1016\/j.socscimed.2006.08.023_bib42","first-page":"672","article-title":"Are all evidence-based practices alike? Problems in the ranking of evidence","volume":"169","author":"Upshur","year":"2003","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"10.1016\/j.socscimed.2006.08.023_bib43","first-page":"565","article-title":"Creutzfeldt\u2013Jakob disease latest unknown in struggle to restore faith in blood supply","volume":"155","author":"Vaughan","year":"1996","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1016\/j.socscimed.2006.08.023_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-136-4-200202190-00011","article-title":"Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s","volume":"136","author":"Weinberg","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"9006","key":"10.1016\/j.socscimed.2006.08.023_bib45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt\u2013Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.socscimed.2006.08.023_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-4-1","article-title":"The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt\u2013Jakob disease","volume":"4","author":"Wilson","year":"2004","journal-title":"BMC Public Health"},{"issue":"7252","key":"10.1016\/j.socscimed.2006.08.023_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.321.7252.17","article-title":"Risk of acquiring Creutzfeldt\u2013Jakob disease from blood transfusions: Systematic review of case-control studies","volume":"321","author":"Wilson","year":"2000","journal-title":"British Medical Journal j"},{"issue":"9","key":"10.1016\/j.socscimed.2006.08.023_bib48","first-page":"1149","article-title":"The challenge of an increasingly expensive blood system","volume":"168","author":"Wilson","year":"2003","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1016\/j.socscimed.2006.08.023_bib49","first-page":"59","article-title":"A policy analysis of major decisions relating to Creutzfeldt\u2013Jakob disease and the blood supply","volume":"165","author":"Wilson","year":"2001","journal-title":"Canadian Medical Association JournalCmaj"},{"issue":"3","key":"10.1016\/j.socscimed.2006.08.023_bib50","first-page":"44","article-title":"How should Canada fund the blood system? An evaluation of the chargeback proposal","volume":"6","author":"Wilson","year":"2003","journal-title":"Hospital Quarterly"},{"key":"10.1016\/j.socscimed.2006.08.023_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/3552391","article-title":"Understanding the impact of intergovernmental relations on public health: Lessons form reform initiatives in the blood system and health surveillance","volume":"30","author":"Wilson","year":"2004","journal-title":"Canadian Public Policy"},{"issue":"10","key":"10.1016\/j.socscimed.2006.08.023_bib52","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1537-2995.2004.04116.x","article-title":"The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt\u2013Jakob disease","volume":"44","author":"Wilson","year":"2004","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.socscimed.2006.08.023_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/tmrv.2003.50007","article-title":"The application of the precautionary principle to the blood system: The Canadian blood system's vCJD donor deferral policy","volume":"17","author":"Wilson","year":"2003","journal-title":"Transfusion Medicine Review"},{"key":"10.1016\/j.socscimed.2006.08.023_bib54","unstructured":"Wingspread conference participants. (1998). Wingspread statement on the precautionary principle. Paper read at Wingspread Conference, January 23\u201325 1998, at Racine, Wisconsin."}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953606004345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953606004345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T12:18:02Z","timestamp":1555849082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953606004345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0277953606004345"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2006.08.023","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}